In a country where nearly one in five adults have HIV/AIDS, Chiedza Maponga, a 1988 UB pharmacy graduate, is working to curb infections and increase availability of treatments.
Maponga, a native of Zimbabwe, helped persuade his country’s government to declare AIDS a national emergency, opening the door to distribution of generic drugs to AIDS patients.
Director of the University at Zimbabwe School of Pharmacy, he also partnered with his UB faculty mentor, Gene D. Morse, to establish the Center for International Pharmacotherapy Education and Research Initiatives (IPERI), which promotes sustainable access to essential drugs in developing countries.
The center is creating hope by applying best pharmacotherapy practices in Zimbabwe and beyond.
Activities include supporting the UB-University of Zimbabwe AIDS International Training and Research Program, a post-graduate training initiative that emphasizes HIV/AIDS clinical pharmacology. The goal is to develop a new generation of Zimbabwean researchers with the skills the country needs to provide and monitor effective treatments for HIV/AIDS.
IPERI's global research and education interests overlap with multiple UB 2020 Strategic Strengths, including Health and Wellness Across the Lifespan, Information and Computing Technology, Integrated Nanostructured Systems, and Molecular Recognition and Biological Systems and Bioinformatics.